BIBIBLIOGRAPHIE

Publié le 29/04/2011

Article réservé aux abonnés

1- Briot K, Trémollières F, Thomas T et al. Quelle est la durée optimale des traitements dans l'ostéoporose post-ménopausique ? Rev Rhum 2007 ; 74 : 27-34

2- Paccou J, Confavreux CB, David C et al. Stabilized severe osteoporosis : should the treatment be stopped ? Joint Bone Spine 2010 ; 77 : S120-27

3- Papapoulos SE, Cremers SC. Prolonged bisphosphonate release after treatment in children. N Engl J Med 2007 ; 356 : 1075-6

4- Watts NB, Chines A, Olsz ynski WP et al. Fracture risk remains reduced one year after discontinuation of risedronate. Osteoporos Int 2008 ; 19 : 365-72

5- Black DM, Schwartz AV, Ensrud KE et al. Effects of continuing or stopping alendronate after 5 years of treatment : the fracture intervention trial long-term extension (FLEX) : a randomized trial. JAMA 2006 ; 296 : 2927-38

6- Schneider JP. Should bisphosphonates be continued indefinitely ? an unusual fracture in a healthy woman on long term alendronate. Geriatrics 2006 ; 61 : 31-3

7- Watts NB, Diab DL. Long term use of bisphosphonates in osteoporosis. J Clin Endocrinol Metab 2010 ; 95 : 1555-65